Note from the Editors on Recent Developments
This extract was created in the absence of an abstract.
We are pleased to announce an important new initiative at RNA. We will be launching a new regular section dedicated to RNA therapeutics. For this, we are pleased to report that Michelle Hastings (University of Michigan) has agreed to serve as Editor for this new section, as RNA Therapeutics Editor. Please see the information below. You will be hearing directly from Michelle, with more details about the new RNA Therapeutics section, when it begins in the very near future.
We have also reorganized the format of the journal, which will now have papers in five categories: Communications (Letters to the Editor, Hypotheses, and Perspectives); Reviews; RNA and Gene Expression; RNA Therapeutics; and Bioinformatics and Databases.
Within the category Communications, Letters to the Editor are intended as a forum for raising or clarifying issues of specific interest to the RNA community. Hypotheses outline novel concepts or new ways of integrating …
